Recommendation from Chemicals Sector

This section gives a recommendation of a stock having stock price below Rs 150 with sound fundamentals and expected to give handsome returns over a one-year time horizon [EasyDNNnews:PaidContentStart]

Kronox Lab Sciences Ltd: BEYOND THE USUAL CHEMICAL

HERE IS WHY
✓  Debt-free, consistently profitable
✓  Unit IV to unlock next growth phase
✓  Purity-led moat, hard to replicate

In specialty chemicals, the strongest competitive edge is not built through aggressive capacity expansion or flashy acquisitions; it is built in the precision of the production process, in the uncompromising standards of purity that define a manufacturer's reputation, and in the steady discipline of serving industries where quality is non-negotiable. That is why Kronox Lab Sciences Limited (KLSL) deserves attention right now, a focused Gujarat-based manufacturer with a clear product niche and a balance sheet that most listed peers would envy, but more importantly, a company that has built its identity around doing one thing exceptionally well rather than many things adequately. In a market where specialty chemical businesses are being scrutinised more carefully for sustainability of margins and quality of earnings, KLSL's debt-free operations, consistent profitability, and niche positioning are no longer just reassuring footnotes; they are the very foundation of a business that has quietly, and convincingly, earned its place among India's most credible specialty chemical franchises.

Incorporated in 2008, its manufacturing operations span three fully operational units in Ekalbara village, Padra taluka, Vadodara district. The company manufactures over 185 high-purity specialty fine chemicals, available in multiple grades and compliant with international standards. These products serve highly regulated industries spanning pharmaceuticals, nutraceuticals, biotech, agrochemicals, and beyond. In terms of revenue mix, approximately 75 per cent comes from the domestic market, with the remaining 25 per cent from exports, a split that has remained consistent over the last four fiscal years.

Therein lies KLSL's moat, the barrier to entry in this space is not merely capital, but years of accumulated technical expertise, multi-standard certifications, and the trust of quality-sensitive customers that take considerable time to build and are nearly impossible to replicate quickly. In an industry where a single deviation in purity can disqualify a supplier entirely, KLSL's consistency and compliance credentials are, in themselves, a formidable and durable competitive advantage.

On the growth front, the most significant trigger is the upcoming Unit IV at GIDC Dahej; all state-level approvals are in place, with central environmental clearance pending, which will substantially expand capacity and introduce newer product families. Simultaneously, the global shift away from China-dependent supply chains is a structural tailwind, with international buyers increasingly seeking certified Indian manufacturers.

On financials, KLSL delivered a strong FY25 with revenue growing 11.5 per cent to ₹100.19 crore, EBITDA expanding 19.26 per cent to ₹35.65 crore, and net profit rising 19.29 per cent to ₹25.47 crore. Into Q3FY26, momentum has moderated, revenue grew 5.26 per cent year-on-year to ₹25.27 crore, EBITDA excluding other income contracted 4.08 per cent to ₹8.02 crore, and net profit grew a marginal 0.9 per cent to ₹6.59 crore. The near-term softness is largely attributable to elevated raw material costs and inventory adjustments, a transient phase rather than a structural concern.

From a valuation standpoint, the stock trades at a TTM PE of 15.63x, well below its three-year median PE of 24.6x; meaning it is available cheaper than what investors have historically paid for it. A PEG ratio of 0.69 signals an attractive entry point relative to growth, while a dividend yield of 0.45 per cent reflects a company sensibly reinvesting into expansion. With Unit IV on the horizon, rising export momentum, and a fundamentally sound business model, the overall outlook remains constructive over the medium to long term. We recommend a BUY.

[EasyDNNnews:PaidContentEnd] [EasyDNNnews:UnPaidContentStart]

[EasyDNNnews:UnPaidContentEnd]